Related Experiment Video
Updated: May 16, 2026

06:11
A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
Dopaminergic involvement in effort-based but not impulsive reward processing in smokers
Tom P Freeman1, Celia J A Morgan, Brigitta Brandner
1Clinical Psychopharmacology Unit, University College London, London WC1E 6BT, United Kingdom. tom.freeman@ucl.ac.uk
Drug and Alcohol Dependence
|November 28, 2012
Summary
Pramipexole, a dopamine agonist, improved reward responsivity in abstinent smokers but did not affect their reward discounting. This suggests potential pharmacological targets for treating nicotine dependence.
Area of Science:
- Neuroscience
- Psychopharmacology
- Addiction Research
Background:
- Smokers exhibit reduced reward responsivity and increased temporal discounting during abstinence.
- These reward processing changes in smokers are not well understood pharmacologically beyond nicotine.
Purpose of the Study:
- To investigate the effects of pramipexole, a dopamine agonist, on reward responsivity and temporal discounting in smokers during nicotine abstinence.
- To explore potential pharmacological interventions for reward processing deficits in nicotine dependence.
Main Methods:
- Double-blind, placebo-controlled, crossover study in smokers after 2 hours of abstinence.
- Assessed reward responsivity using an effort-based card sorting task.
- Measured temporal discounting of monetary reward using Area Under the Curve (AUC) analysis.
Main Results:
- Pramipexole enhanced reward responsivity, as indicated by increased card sorting under rewarded conditions.
- Pramipexole did not significantly alter temporal discounting of monetary reward.
- Pramipexole decreased positive affect and increased drowsiness.
Conclusions:
- A single dose of pramipexole can improve effort-based reward responsivity in smokers.
- Pramipexole does not modify temporal discounting in this population.
- Findings suggest dopamine agonists may offer targets for treating reward deficits in nicotine dependence.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
